Fingerprint
Dive into the research topics of 'S0502: A SWOG phase III randomized study of imatinib, with or without bevacizumab, in patients with untreated metastatic or unresectable gastrointestinal stromal tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically